"Hormone Antagonists" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Chemical substances which inhibit the function of the endocrine glands, the biosynthesis of their secreted hormones, or the action of hormones upon their specific sites.
| Descriptor ID |
D006727
|
| MeSH Number(s) |
D06.347 D27.505.696.399.450
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Hormone Antagonists".
Below are MeSH descriptors whose meaning is more specific than "Hormone Antagonists".
This graph shows the total number of publications written about "Hormone Antagonists" by people in this website by year, and whether "Hormone Antagonists" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2007 | 1 | 0 | 1 |
| 2009 | 0 | 1 | 1 |
| 2010 | 1 | 0 | 1 |
| 2012 | 1 | 0 | 1 |
| 2017 | 1 | 0 | 1 |
| 2018 | 1 | 1 | 2 |
| 2019 | 2 | 0 | 2 |
| 2020 | 0 | 1 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Hormone Antagonists" by people in Profiles.
-
Roles of steroid receptors in the lung and COVID-19. Essays Biochem. 2021 12 17; 65(6):1025-1038.
-
Willingness of Women with Endometriosis Planning to Undergo IVF to Participate in a Randomized Clinical Trial and the Effects of the COVID-19 Pandemic on Potential Participation. Reprod Sci. 2022 02; 29(2):620-626.
-
Sex Disparities in COVID-19 Severity and Outcome: Are Men Weaker or Women Stronger? Neuroendocrinology. 2021; 111(11):1066-1085.
-
Growth Hormone-Releasing Hormone Receptor Antagonist Modulates Lung Inflammation and Fibrosis due to Bleomycin. Lung. 2019 10; 197(5):541-549.
-
Gonadotropin releasing hormone antagonist use in controlled ovarian stimulation and intrauterine insemination cycles in women with polycystic ovary syndrome. Taiwan J Obstet Gynecol. 2019 Mar; 58(2):234-238.
-
Oxidative Stress in Women Treated with Atosiban for Impending Preterm Birth. Oxid Med Cell Longev. 2018; 2018:3919106.
-
Bromocriptine treatment in patients with peripartum cardiomyopathy and right ventricular dysfunction. Clin Res Cardiol. 2019 Mar; 108(3):290-297.
-
GnRH antagonist rescue of a short-protocol IVF/ICSI cycle and GnRH agonist triggering to prevent ovarian hyperstimulation syndrome: two case reports. Clin Exp Obstet Gynecol. 2017; 44(2):279-282.
-
Vasopressin receptor antagonist in the treatment of the syndrome of inappropriate antidiuretic hormone in general hospital practice. Endocr J. 2012; 59(10):903-9.
-
Evaluation of bromocriptine in the treatment of acute severe peripartum cardiomyopathy: a proof-of-concept pilot study. Circulation. 2010 Apr 06; 121(13):1465-73.